Annecy, France—If ever there was a scientific endeavor calling for patience and impatience in equal measure, the quest for an effective HIV vaccine would be it.
On one hand, with 40 million people infected worldwide with HIV and the number growing by some 15 000 newly infected individuals each day, the need for a vaccine has never been more urgent. On the other hand, there are a number of hurdles that have made HIV vaccine research a painfully slow process that demands patience as well as perseverance. For example, HIV's mutability in an infected individual and the global diversity of HIV strains and subtypes (clades), HIV's lifelong persistence in the body, and the need to induce both mucosal and systemic immunity to provide protect against different routes of infection are among the many problems vexing vaccine researchers.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.